TRANSTHERA-B (02617) Selected for Inclusion in Hang Seng Index Series

Stock News

2025/08/25

TRANSTHERA-B (02617) announced that following the quarterly review results published by Hang Seng Indexes Company Limited on August 22, 2025, the company has been selected for inclusion in various Hang Seng index series, effective September 8, 2025.

The company will be included in the following indices: 1. Hang Seng Composite Index; 2. Hang Seng Composite Industry Index - Healthcare; 3. Hang Seng Composite MidCap & SmallCap Index; 4. Hang Seng Composite SmallCap Index; 5. Hang Seng Healthcare Index; 6. Hang Seng Biotech Index; 7. Hang Seng Stock Connect Biotech Index; 8. Hang Seng Stock Connect Biotech Select Index; and 9. Hang Seng Stock Connect Pharmaceuticals & Biotechnology (Investable) Index.

The company stated that its inclusion in the Hang Seng Composite Index and the aforementioned indices reflects rising investor recognition.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1139681939"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1139681939\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1139681939?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-25 22:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139681939","market":"other","top_or_hot":-1,"title":"TRANSTHERA-B (02617) Selected for Inclusion in Hang Seng Index Series","media":"Stock News","content":"<p>TRANSTHERA-B (02617) announced that following the quarterly review results published by Hang Seng Indexes Company Limited on August 22, 2025, the company has been selected for inclusion in various Hang Seng index series, effective September 8, 2025.</p>\n<p>The company will be included in the following indices: 1. Hang Seng Composite Index; 2. Hang Seng Composite Industry Index - Healthcare; 3. Hang Seng Composite MidCap & SmallCap Index; 4. Hang Seng Composite SmallCap Index; 5. Hang Seng Healthcare Index; 6. Hang Seng Biotech Index; 7. Hang Seng Stock Connect Biotech Index; 8. Hang Seng Stock Connect Biotech Select Index; and 9. Hang Seng Stock Connect Pharmaceuticals & Biotechnology (Investable) Index.</p>\n<p>The company stated that its inclusion in the Hang Seng Composite Index and the aforementioned indices reflects rising investor recognition.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TRANSTHERA-B (02617) Selected for Inclusion in Hang Seng Index Series</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTRANSTHERA-B (02617) Selected for Inclusion in Hang Seng Index Series\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-08-25 22:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TRANSTHERA-B (02617) announced that following the quarterly review results published by Hang Seng Indexes Company Limited on August 22, 2025, the company has been selected for inclusion in various Hang Seng index series, effective September 8, 2025.</p>\n<p>The company will be included in the following indices: 1. Hang Seng Composite Index; 2. Hang Seng Composite Industry Index - Healthcare; 3. Hang Seng Composite MidCap & SmallCap Index; 4. Hang Seng Composite SmallCap Index; 5. Hang Seng Healthcare Index; 6. Hang Seng Biotech Index; 7. Hang Seng Stock Connect Biotech Index; 8. Hang Seng Stock Connect Biotech Select Index; and 9. Hang Seng Stock Connect Pharmaceuticals & Biotechnology (Investable) Index.</p>\n<p>The company stated that its inclusion in the Hang Seng Composite Index and the aforementioned indices reflects rising investor recognition.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSI","symbol_name":"恒生指数","start_time":0,"source_url":"","article_id":"1139681939","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139681939","pubTimestamp":1756132713,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"TRANSTHERA-B (02617) announced that following the quarterly review results published by Hang Seng Indexes Company Limited on August 22, 2025, the company has been selected for inclusion in various...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159271":"恒生指数","513600":"恒生指数ETF南方","HSI":"恒生指数","02617":"药捷安康-B","02833":"恒指ETF","BK1161":"生物科技"},"translate_title":"Tranthera-B(02617)入选恒生指数系列","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159271":1,"513600":1,"HSI":1,"HHImain":1,"HSImain":1,"02617":1,"MHImain":1,"02833":1,"MCHmain":1},"content_text":"TRANSTHERA-B (02617) announced that following the quarterly review results published by Hang Seng Indexes Company Limited on August 22, 2025, the company has been selected for inclusion in various Hang Seng index series, effective September 8, 2025.\nThe company will be included in the following indices: 1. Hang Seng Composite Index; 2. Hang Seng Composite Industry Index - Healthcare; 3. Hang Seng Composite MidCap & SmallCap Index; 4. Hang Seng Composite SmallCap Index; 5. Hang Seng Healthcare Index; 6. Hang Seng Biotech Index; 7. Hang Seng Stock Connect Biotech Index; 8. Hang Seng Stock Connect Biotech Select Index; and 9. Hang Seng Stock Connect Pharmaceuticals & Biotechnology (Investable) Index.\nThe company stated that its inclusion in the Hang Seng Composite Index and the aforementioned indices reflects rising investor recognition.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}